203 filings
Page 7 of 11
8-K
ner9jucomd yoym
17 Jun 09
Departure of Directors or Certain Officers
12:00am
8-K
t2qn49 0d3
29 May 09
TorreyPines Therapeutics Announces its Board of Directors’ Approval of Plan of Liquidation and Dissolution
12:00am
8-K
vg05zba9 20fw447ei
1 May 09
TorreyPines Therapeutics Reports First Quarter 2009 Financial Results
12:00am
8-K
o81xbcr
24 Apr 09
Termination of a Material Definitive Agreement
12:00am
8-K
k9xttw7
2 Apr 09
TorreyPines Therapeutics Receives Notice of Non-Compliance with Nasdaq
12:00am
8-K
vwwkfigg262syh1q33v0
31 Mar 09
Cost Associated with Exit or Disposal Activities
12:00am
8-K
1qfjxyf 11t
27 Mar 09
TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results
12:00am
8-K
m5ph uysg
9 Feb 09
Departure of Directors or Certain Officers
12:00am
8-K
vilqdkdi2l68gmc 9fq
2 Dec 08
Other Events
12:00am
8-K
5te yhtyp
1 Dec 08
Other Events
12:00am
8-K
fgcn8ivaovso1ky55
26 Nov 08
TorreyPines Therapeutics Enters into Agreement to
12:00am
8-K
xzbmawvfrm4jf083s q3
12 Nov 08
TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a
12:00am
8-K
c62u3644yt ewaee
12 Nov 08
TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments
12:00am
8-K
js6f7ileoqbh71q6enl5
10 Nov 08
Entry into a Material Definitive Agreement
12:00am
8-K
emih16qa
7 Oct 08
Amended and Restated Employment Agreement
12:00am
8-K
d6jaktfdsqboqr5cld
2 Oct 08
TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting with FDA for Tezampanel
12:00am
8-K
mjk5wp2o8zk67ecaxd
25 Sep 08
TorreyPines Therapeutics Strategically Repositions as Development Company
12:00am
8-K
3inc4rvzowl3z6o dbz
26 Aug 08
TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
12:00am
8-K
1rlqbkigo9z0283
8 Aug 08
TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results
12:00am
8-K
0trov07vxd qozvzqxt
23 Jun 08
Departure of Directors or Principal Officers
12:00am